Related Experiment Video
Updated: Jan 19, 2026

07:27
Exergaming in Older People Living with HIV Improves Balance, Mobility and Ameliorates Some Aspects of Frailty
Published on: October 6, 2016
10.6K
Exercise Interventions in Huntington's Disease: An Individual Patient Data Meta-Analysis
Rebecca Playle1, Polyxeni Dimitropoulou1, Mark Kelson2
1Centre for Trials Research Cardiff University Cardiff United Kingdom.
Movement Disorders Clinical Practice
|September 21, 2019
Summary
Physical activity did not improve motor scores in Huntington's disease (HD) patients in short trials. Longer, supervised exercise interventions are needed, with standardized outcomes for future research.
Area of Science:
- Neurology
- Exercise Science
- Clinical Trials
Background:
- Physical activity shows potential benefits for Huntington's disease (HD).
- Previous studies were underpowered to demonstrate significant effects.
- This meta-analysis combined data from five randomized controlled feasibility trials.
Purpose of the Study:
- To evaluate the efficacy of physical activity interventions in Huntington's disease.
- To analyze pooled data from multiple feasibility trials.
- To identify optimal exercise parameters for future HD research.
Main Methods:
- Individual patient data meta-analysis of five randomized controlled feasibility trials.
- Interventions included supervised and self-directed physical activity (aerobic, strength, endurance, flexibility, task training).
- Primary outcome: modified Unified Huntington's Disease Rating Motor Score; numerous secondary outcomes assessed.
Main Results:
- 121 participants provided complete data; moderate risk of bias, but primary outcomes were blind assessed.
- Pooled effect estimate for motor score favored control (0.2, 95% CI -2.1 to 2.6), with no significant exercise effect.
- Considerable heterogeneity observed between the studies.
Conclusions:
- Short-duration physical activity interventions showed no significant benefit on motor function in HD.
- Future trials require longer durations and supervised components adhering to FITT principles.
- Standardization of outcome measures is crucial for future exercise research in HD.
More Related Videos
Related Concept Videos
Parkinson's Disease: Treatment
1000
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1000
Parkinson's Disease: Overview
1.8K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K
Alzheimer's Disease: Treatment
831
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
831

